Research.Patient.info

metastatic esophagogastric adenocarcinoma (Stage IV) research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingPhase I and Phase II (Integrated)- Other
A phase Ib/II single-arm, multicenter study of sacituzumab-govitecan, a TROP-2 targeting antibody linked with SN38, for patients with metastatic esophagogastric adenocarcinoma
This study is testing a new medicine, Sacituzumab Govitecan, for people with advanced oesophageal or stomach cancer that has spread. It aims to see how well the medicine works by checking if tumours shrink. This is an early-stage study to learn more about this treatment.
Germany · Austria